Show results for
Refine by
Locations
- USA
- Alabama
- Alaska
- Arizona
- Arkansas
- California
- Colorado
- Connecticut
- Delaware
- District Of Columbia
- Florida
- Georgia (Us)
- Hawaii
- Idaho
- Illinois
- Indiana
- Iowa
- Kansas
- Kentucky
- Louisiana
- Maine
- Maryland
- Massachusetts
- Michigan
- Minnesota
- Mississippi
- Missouri
- Montana
- Nebraska
- Nevada
- New Hampshire
- New Jersey
- New Mexico
- New York
- North Carolina
- North Dakota
- Ohio
- Oklahoma
- Oregon
- Pennsylvania
- Rhode Island
- South Carolina
- South Dakota
- Tennessee
- Texas
- Utah
- Vermont
- Virginia
- Washington
- West Virginia
- Wisconsin
- Wyoming
Drugs For The Treatment Services In Usa
15 services found
Manufactured by:Creative Biolabs based inShirley, NEW YORK (USA)
Any malfunction of key enzymes (mutation, overproduction, underproduction or deletion) can lead to diseases. Therefore, enzymes have long been considered as important drug targets for the treatment of major human ...
by:IMARC Group based inNoida, INDIA
Market/Product assessment reports give our clients a deep insight into the dynamics of the Industry. These studies serve as an analytical as well as a statistical tool to understand the regulations, trends, market structure, sales, supply chain, competitive landscape, drivers, restraints and the outlook of the Industry. Our market research reports serve as an excellent guide for investors, ...
Manufactured by:UroTech based inFranklin, TENNESSEE (USA)
Taking medications to counteract the condition causing the stone to ...
by:Natera, Inc. based inAustin, TEXAS (USA)
Why partner with Signatera for your clinical trial? Clinically validated across multiple solid tumors, Signatera has shown to predict relapse in >98% of patients without further treatment. Experienced team with Global reach: CE Mark, three FDA Breakthrough Device Designations, 8 Non-Significant Risk (NSR) determinations. >60 Natera IP assets covering ctDNA MRD and ...
by:Center for Toxicology and Environmental Health, L.L.C. (CTEH) based inNorth Little Rock, ARKANSAS (USA)
CTEH®’s pharmacology & toxicology professionals have extensive experience assessing the human toxicity of drugs and chemicals, and drug interactions and adverse reactions. CTEH® provides additional experience in pharmacokinetic analysis. Levels of drugs or chemicals in blood and/or urine are frequently key pieces of information in accidents, worker exposure issues, and in ...
by:Day Zero Diagnostics Inc. based inBoston, MASSACHUSETTS (USA)
Antibiotic resistance is an escalating global crisis, where the spread of drug resistance is outpacing the development of new ...
Manufactured by:Cloud-Clone Corp. based inKaty, TEXAS (USA)
The development of human disease is very complex, to itself as experimental object to in-depth study of the mechanism of disease, the accumulation of clinical experience not only in time and space are limited and many experiments on the moral are restricted. Animal models can provides the basic platform for the study of safety research of drugs, biological products, medical polymer materials, ...
Manufactured by:HemoShear Therapeutics, Inc. based inCharlottesville, VIRGINIA (USA)
Using our powerful REVEAL-TxTM drug discovery platform, our scientists are identifying and validating promising approaches to develop novel treatments aiming to extend and improve the quality of life of patients with rare diseases. In our most advanced program, the company is conducting a phase 2 clinical trial of HST5040, an oral small molecule investigational ...
Manufactured by:CDBioSciences - VLPlant based inShirley, NEW YORK (USA)
cVLPs are formed from VLPs and ligands through genetic fusion or chemical conjugation. As a leading global provider of custom services, CD BioSciences has advanced facilities and experienced scientists dedicated to cVLPs development services to help our customers develop vaccines, nanomaterials and diagnostic ...
by:elminda Ltd. based inHerzliya, ISRAEL
CNS drugs exhibit the lowest approval success rates due to multiple challenges such as lack of efficacy in early and advanced stages of development, Poor target selection / engagement, poor translation from pre-clinical models and disease heterogeneity. BNA may contribute in CNS research and drug development by adding new objective endpoints, assisting in ...
by:iFyber, LLC based inIthaca, NEW YORK (USA)
This detectable response can vary based on the specific medical intervention and may give clues regarding disease progression, wound healing, or the physiological side-effects of a device or drug ...
by:iFyber, LLC based inIthaca, NEW YORK (USA)
At iFyber, we have access to state-of-the-art equipment and facilities that allow our highly trained staff to process and stain a variety of tissue types for research and development purposes. We specialize in working with clients across the medical device, wound care, and regenerative medicine fields to customize histological techniques for signal quantification or morphological measurements in ...
Manufactured by:NeuroOne Medical Technologies Corporation based inEden Prairie, MINNESOTA (USA)
Neurons communicate through electrical and chemical signals. The specific properties of the neurons composing a brain area and their connections with neurons in other brain areas, define the function of a brain area (e.g. language, vision, ...
by:CureMatch, Inc. based inSan Diego, CALIFORNIA (USA)
CureMatch provides a scored and ranked listing of the most well-adapted personalized medicine treatment options. The comprehensive analysis considers commonly used treatments, as well as targeted therapy, immunotherapy, hormone therapy, and newly approved oncology drugs. These options are presented either alone (monotherapy) or in combinations of ...
Manufactured by:MedGenome Inc. based inCounty of New Castle, DELAWARE (USA)
Profiling the Tumor Microenvironment: Using a genomics based approach to analyze the tumor microenvironment can provide unique insights beyond IHC and FACS methods. OncoPeptTUME deeply interrogates RNA-Seq data sets to produce high resolution mapping of the tumor microenvironment using proprietary cell type specific gene expression signatures. OncoPeptTUME provides a critical assessment of the ...